Acute rhabdomyolysis under treatment with HMG-CoA reductase inhibitors (" statins") is a
group-specific if rare side effect. Muscle toxicity of statins can be potentiated by medication …

Background Statins have a well-established role in prevention of vascular events but are
associated with muscle-related adverse events. The dose relationship with these adverse …

Purpose. A case of early-onset rhabdomyolysis in a patient treated with atorvastatin is
described. Summary. A 17-year-old Indian boy weighing 55 kg was admitted to the hospital …

Myopathy, including rhabdomyolysis, is a well-known, albeit rare complication of statin
therapy. Predisposing factors include comorbidities and the concomitant use of cytochrome …

A rabdomiólise tem sido motivo de publicação na literatura médica há mais de 50 anos. Nas
últimas décadas, com o advento das estatinas, usadas na prevenção primária e secundária …

Purpose: To identify case reports of statin-induced rhabdomyolysis and summarize common
predisposing factors, symptoms, diagnostic findings, functional outcomes, characteristics …

OBJECTIVE: To demonstrate a case of rhabdomyolysis with acute renal failure in a patient
receiving fluvastatin and to present evidence that this was an adverse drug reaction to …

Rhabdomyolysis is a syndrome characterized by muscle necrosis which causes the release
of myoglobin into the bloodstream. The manifestations of this syndrome range from …

The hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely
used hypolipidemic agents which decrease cardiovascular morbidity and mortality in both …

A case of a woman diagnosed to have rhabdomyolysis is presented. It was attributed to
simvastatin she had been receiving for 1 year. Based on pathogenesis and medical …